FDA seeks Public Comments on Homoeopathic Product Regulation
Reproduced from Web: http://www.regulations.gov/#!documentDetail;D=FDA-2015-N-0540-0001 The Food and Drug Administration (FDA) is has announced a public hearing to obtain information and comments from stakeholders about the current use of human drug and biological products labeled as homeopathic, as well as the Agency’s regulatory framework for such products. The products under consideration include prescription drugs and biological … Read more
